Chinese Journal of Chromatography ›› 2023, Vol. 41 ›› Issue (10): 911-920.DOI: 10.3724/SP.J.1123.2023.03006
• Articles • Previous Articles Next Articles
YANG Cheng1, SHI Yanmei1,*(), PANG Tiantian1, LIU Xiaobing1, ZHANG Zhiyu1, HU Kai1,*(
), ZHANG Shusheng2
Received:
2023-03-09
Online:
2023-10-08
Published:
2023-10-23
Supported by:
CLC Number:
YANG Cheng, SHI Yanmei, PANG Tiantian, LIU Xiaobing, ZHANG Zhiyu, HU Kai, ZHANG Shusheng. Preparation of sulfonic acid functionalized covalent organic framework solid phase microextraction fibers and their application in the analysis of neurotransmitters in the mouse brain[J]. Chinese Journal of Chromatography, 2023, 41(10): 911-920.
Compound | Precursor ion (m/z) | Fragment ion (m/z) | Collision energy/V | Radio frequency lens/V | IS |
---|---|---|---|---|---|
γ-Aminobutyric acid (GABA) | 104.1 | 45.1 | 21.5 | 30 | GABA-d6 |
104.1 | 87.1 | 10.5 | 30 | ||
Choline (Cho) | 104.1 | 45.1 | 21.8 | 46 | Cho-d9 |
104.1 | 60.1 | 17.9 | 46 | ||
Dopamine (DA) | 137.1 | 91.1 | 17.9 | 47 | DA-d4 |
137.1 | 119.1 | 12.6 | 47 | ||
Glutamate (Glu) | 148.0 | 84.1 | 16.1 | 38 | GABA-d6 |
148.0 | 130.0 | 7.7 | 38 | ||
Norepinephrine (NE) | 152.1 | 107.1 | 18.1 | 61 | L-Glu-15N |
152.1 | 135.0 | 12.3 | 61 | ||
5-Hydroxytryptamine (5-HT) | 160.1 | 115.1 | 23.2 | 69 | L-Glu-15N |
160.1 | 132.1 | 17.3 | 69 | ||
Epinephrine (EP) | 166.1 | 107.1 | 19.6 | 72 | DA-d4 |
166.1 | 135.1 | 14.9 | 72 | ||
γ-Aminobutyric acid-d6(GABA-d6) | 110.2 | 93.1 | 10.7 | 30 | |
Dopamine-d4(DA-d4) | 141.1 | 94.1 | 18.5 | 61 | |
L-Glutamine-15N (L-Glu-15N) | 149.1 | 85.1 | 14.8 | 30 | |
Choline-d9(Cho-d9) | 113.2 | 69.1 | 18.4 | 46 |
Table 1 MS parameters for the seven neurotransmitters (NTs) and internal standards (ISs)
Compound | Precursor ion (m/z) | Fragment ion (m/z) | Collision energy/V | Radio frequency lens/V | IS |
---|---|---|---|---|---|
γ-Aminobutyric acid (GABA) | 104.1 | 45.1 | 21.5 | 30 | GABA-d6 |
104.1 | 87.1 | 10.5 | 30 | ||
Choline (Cho) | 104.1 | 45.1 | 21.8 | 46 | Cho-d9 |
104.1 | 60.1 | 17.9 | 46 | ||
Dopamine (DA) | 137.1 | 91.1 | 17.9 | 47 | DA-d4 |
137.1 | 119.1 | 12.6 | 47 | ||
Glutamate (Glu) | 148.0 | 84.1 | 16.1 | 38 | GABA-d6 |
148.0 | 130.0 | 7.7 | 38 | ||
Norepinephrine (NE) | 152.1 | 107.1 | 18.1 | 61 | L-Glu-15N |
152.1 | 135.0 | 12.3 | 61 | ||
5-Hydroxytryptamine (5-HT) | 160.1 | 115.1 | 23.2 | 69 | L-Glu-15N |
160.1 | 132.1 | 17.3 | 69 | ||
Epinephrine (EP) | 166.1 | 107.1 | 19.6 | 72 | DA-d4 |
166.1 | 135.1 | 14.9 | 72 | ||
γ-Aminobutyric acid-d6(GABA-d6) | 110.2 | 93.1 | 10.7 | 30 | |
Dopamine-d4(DA-d4) | 141.1 | 94.1 | 18.5 | 61 | |
L-Glutamine-15N (L-Glu-15N) | 149.1 | 85.1 | 14.8 | 30 | |
Choline-d9(Cho-d9) | 113.2 | 69.1 | 18.4 | 46 |
Fig. 4 Optimization of (a) desorption solvents, (b) extraction time and (c) desorption time Desorption solvents: A. formic acid (FA)-H2O-MeOH-ACN (0.4∶39.6∶30∶30, v/v/v/v); B. 1% (v/v) acetic acid aqueous solution; C. 1% (v/v) formic acid aqueous solution; D. acetic acid-H2O-MeOH-ACN (0.4∶39.6∶30∶30, v/v/v/v); E. 1% (v/v) FA in MeOH; F. 1% (v/v) acetic acid in MeOH; G. FA-MeOH-H2O (0.5∶49.5∶50, v/v/v).
Analyte | Linear range/ (μg/mL) | Linear equation | LOQ/ (μg/mL) | r2 |
---|---|---|---|---|
GABA | 1-3000 | y=1.02×10-2x-3.84×10-2 | 5 | 0.9995 |
Cho | 1-3000 | y=1.00×10-2x-2.09×10-2 | 5 | 0.9996 |
Glu | 1-3000 | y=1.25×10-2x+2.99×10-1 | 3 | 0.9991 |
DA | 0.001-2 | y=8.70×10-3x+6.71×10-1 | 0.003 | 0.9988 |
NE | 0.005-2 | y=3.00×10-3x+2.31×10-1 | 0.005 | 0.9964 |
5-HT | 0.001-2 | y=2.40×10-3x+6.09×10-2 | 0.003 | 0.9987 |
EP | 0.005-2 | y=2.90×10-3x+2.18×10-1 | 0.005 | 0.9971 |
Table 2 Linear ranges, linear equations, limits of quantification (LOQs) and correlation coefficients (r2) of the seven NTs
Analyte | Linear range/ (μg/mL) | Linear equation | LOQ/ (μg/mL) | r2 |
---|---|---|---|---|
GABA | 1-3000 | y=1.02×10-2x-3.84×10-2 | 5 | 0.9995 |
Cho | 1-3000 | y=1.00×10-2x-2.09×10-2 | 5 | 0.9996 |
Glu | 1-3000 | y=1.25×10-2x+2.99×10-1 | 3 | 0.9991 |
DA | 0.001-2 | y=8.70×10-3x+6.71×10-1 | 0.003 | 0.9988 |
NE | 0.005-2 | y=3.00×10-3x+2.31×10-1 | 0.005 | 0.9964 |
5-HT | 0.001-2 | y=2.40×10-3x+6.09×10-2 | 0.003 | 0.9987 |
EP | 0.005-2 | y=2.90×10-3x+2.18×10-1 | 0.005 | 0.9971 |
Analyte | Accuracies/% | RSDs/% | AMEs/% | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Low | Medium | High | Low | Medium | High | Low | Medium | High | |||
GABA | 13.83 | 6.68 | 3.40 | 0.80 | 1.68 | 7.66 | 85.04 | 117.92 | 89.22 | ||
Cho | 17.58 | 8.17 | 2.52 | 1.84 | 2.58 | 7.25 | 101.63 | 108.13 | 102.22 | ||
Glu | 9.38 | 7.31 | 2.08 | 5.21 | 3.96 | 5.99 | 90.28 | 97.29 | 91.46 | ||
DA | 8.12 | 7.90 | 15.75 | 7.59 | 9.50 | 5.65 | 111.71 | 82.22 | 110.66 | ||
NE | 14.79 | 6.21 | 17.72 | 1.81 | 2.88 | 5.87 | 105.46 | 96.35 | 108.99 | ||
5-HT | 6.21 | 9.69 | 15.86 | 3.05 | 1.35 | 1.33 | 84.78 | 87.19 | 107.28 | ||
EP | 10.55 | 8.16 | 8.20 | 1.67 | 1.69 | 3.25 | 89.20 | 100.60 | 104.91 |
Table 3 Accuracies, precisions and AMEs of the seven NTs in brain homogenate at three spiked levels (n=3)
Analyte | Accuracies/% | RSDs/% | AMEs/% | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Low | Medium | High | Low | Medium | High | Low | Medium | High | |||
GABA | 13.83 | 6.68 | 3.40 | 0.80 | 1.68 | 7.66 | 85.04 | 117.92 | 89.22 | ||
Cho | 17.58 | 8.17 | 2.52 | 1.84 | 2.58 | 7.25 | 101.63 | 108.13 | 102.22 | ||
Glu | 9.38 | 7.31 | 2.08 | 5.21 | 3.96 | 5.99 | 90.28 | 97.29 | 91.46 | ||
DA | 8.12 | 7.90 | 15.75 | 7.59 | 9.50 | 5.65 | 111.71 | 82.22 | 110.66 | ||
NE | 14.79 | 6.21 | 17.72 | 1.81 | 2.88 | 5.87 | 105.46 | 96.35 | 108.99 | ||
5-HT | 6.21 | 9.69 | 15.86 | 3.05 | 1.35 | 1.33 | 84.78 | 87.19 | 107.28 | ||
EP | 10.55 | 8.16 | 8.20 | 1.67 | 1.69 | 3.25 | 89.20 | 100.60 | 104.91 |
|
Viewed | ||||||||||||||||||||||||||||||||||||||||||||||||||
Full text 298
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Abstract 207
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||